Nadine D. Arnold
Sheffield, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Vascular smooth muscle cell-derived osteoprotegerin drives pulmonary arterial hypertension via AKT activation and is attenuated by monoclonal antibody therapy.
Journal: Cardiovascular research
Published: October 09, 2025
The hepcidin-ferroportin axis influences mitochondrial function, proliferation, and migration in pulmonary artery endothelial and smooth muscle cells.
Journal: Pulmonary circulation
Published: February 02, 2024
Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.
Journal: BMC pulmonary medicine
Published: July 20, 2022
Altered Macrophage Polarization Induces Experimental Pulmonary Hypertension and Is Observed in Patients With Pulmonary Arterial Hypertension.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: November 05, 2020
Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension.
Journal: American journal of respiratory and critical care medicine
Published: September 14, 2018
Selective improvement of pulmonary arterial hypertension with a dual ETA/ETB receptors antagonist in the apolipoprotein E-/- model of PAH and atherosclerosis.
Journal: Pulmonary circulation
Published: December 21, 2017
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension.
Journal: Nature communications
Published: September 21, 2017
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.
Journal: BMC pulmonary medicine
Published: July 03, 2017
Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension.
Journal: Circulation. Cardiovascular interventions
Published: November 11, 2015
MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension.
Journal: The Journal of clinical investigation
Published: June 23, 2015
Coronary stents seeded with human trophoblastic endovascular progenitor cells show accelerated strut coverage without excessive neointimal proliferation in a porcine model.
Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published: October 21, 2014
Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension.
Journal: The Journal of experimental medicine
Published: October 17, 2012
Last Updated: 09/26/2026